{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T00:18:24Z","timestamp":1793060304450,"version":"4.5.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular Graphics and Modelling"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.jmgm.2019.06.008","type":"journal-article","created":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T09:21:38Z","timestamp":1559899298000},"page":"91-104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"special_numbering":"C","title":["Identification of novel small molecules against GSK3\u03b2 for Alzheimer's disease using chemoinformatics approach"],"prefix":"10.1016","volume":"91","author":[{"given":"Rohit","family":"Shukla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nupur S.","family":"Munjal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiratha Raj","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmgm.2019.06.008_bib1","series-title":"World Alzheimer Report 2018, the State of the Art of Dementia Research: New Frontiers","author":"Patterson","year":"2018"},{"key":"10.1016\/j.jmgm.2019.06.008_bib3","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S0197-4580(02)00036-2","article-title":"Alzheimer's disease and Alzheimer's dementia: distinct but overlapping entities","volume":"23","author":"Blass","year":"2002","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.jmgm.2019.06.008_bib4","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s12539-016-0144-0","article-title":"A\u00a0new decision tree to solve the puzzle of alzheimer's disease pathogenesis through standard diagnosis scoring system","volume":"9","author":"Kumar","year":"2017","journal-title":"Interdiscip. Sci. Comput. Life Sci."},{"key":"10.1016\/j.jmgm.2019.06.008_bib5","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1504\/IJBRA.2017.085856","article-title":"Analysis for biological network properties of Alzheimer's disease associated gene set by enrichment and topological examinations","volume":"13","author":"Kumar","year":"2017","journal-title":"Int. J. Bioinform. Res. Appl."},{"key":"10.1016\/j.jmgm.2019.06.008_bib6","article-title":"Computational and in-vitro validation of natural molecules as potential Acetylcholinesterase inhibitors and neuroprotective agents","author":"Kumar","year":"2018","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.jmgm.2019.06.008_bib7","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S1474-4422(03)00502-7","article-title":"Treatment of Alzheimer's disease: current status and new perspectives","volume":"2","author":"Scarpini","year":"2003","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jmgm.2019.06.008_bib8","doi-asserted-by":"crossref","DOI":"10.1021\/acschemneuro.9b00037","article-title":"Synergistic effect of amyloid-\u03b2 and tau disrupts neural circuits","author":"Tripathi","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.jmgm.2019.06.008_bib9","article-title":"Phospho-tau impairs nuclear-cytoplasmic transport","author":"Tripathi","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.jmgm.2019.06.008_bib10","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1021\/acschemneuro.9b00079","article-title":"Abnormal microtubule dynamics impair the nuclear-cytoplasmic transport in dementia","volume":"10","author":"Tripathi","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.jmgm.2019.06.008_bib11","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.ejmech.2016.09.057","article-title":"Design, synthesis, in-silico and biological evaluation of novel donepezil derivatives as multi-target-directed ligands for the treatment of Alzheimer's disease","volume":"125","author":"Mishra","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jmgm.2019.06.008_bib12","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jmgm.2016.03.001","article-title":"Docking and ADMET prediction of few GSK-3 inhibitors divulges 6-bromoindirubin-3-oxime as a potential inhibitor","volume":"65","author":"Nisha","year":"2016","journal-title":"J.\u00a0Mol. Graph. Model."},{"key":"10.1016\/j.jmgm.2019.06.008_bib13","doi-asserted-by":"crossref","first-page":"9258578","DOI":"10.1155\/2016\/9258578","article-title":"Molecular docking and in silico ADMET study reveals acylguanidine 7a as a potential inhibitor of \u03b2-secretase","volume":"2016","author":"Nisha","year":"2016","journal-title":"Adv. Bioinform."},{"key":"10.1016\/j.jmgm.2019.06.008_bib14","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/jphp.12919","article-title":"Muscarinic and nicotinic acetylcholine receptor agonists: current scenario in Alzheimer's disease therapy","volume":"70","author":"Verma","year":"2018","journal-title":"J.\u00a0Pharm. Pharmacol."},{"key":"10.1016\/j.jmgm.2019.06.008_bib15","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2174\/2212796812666180416145232","article-title":"In silico screening and molecular interaction studies of tetrahydrocannabinol and its derivatives with acetylcholine binding protein","volume":"12","author":"Panigrahi","year":"2018","journal-title":"Curr. Chem. Biol."},{"key":"10.1016\/j.jmgm.2019.06.008_bib16","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/alzrt269","article-title":"Alzheimer's disease drug-development pipeline: few candidates, frequent failures","volume":"6","author":"Cummings","year":"2014","journal-title":"Alzheimer's Res. Ther."},{"key":"10.1016\/j.jmgm.2019.06.008_bib17","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/17460441.2018.1445084","article-title":"Recent developments with tau-based drug discovery","volume":"13","author":"Iqbal","year":"2018","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.jmgm.2019.06.008_bib18","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/nrd.2017.155","article-title":"Tau-based therapies in neurodegeneration: opportunities and challenges","volume":"16","author":"Li","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jmgm.2019.06.008_bib19","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/nrd2111","article-title":"Untangling tau hyperphosphorylation in drug design for neurodegenerative diseases","volume":"6","author":"Mazanetz","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jmgm.2019.06.008_bib20","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ejmech.2012.12.014","article-title":"Evidence for a new binding mode to GSK-3: allosteric regulation by the marine compound palinurin","volume":"60","author":"Bidon-Chanal","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jmgm.2019.06.008_bib21","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.pharmthera.2014.11.016","article-title":"Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases","volume":"0","author":"Beurel","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jmgm.2019.06.008_bib22","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.18632\/oncotarget.2037","article-title":"GSK-3 as potential target for therapeutic intervention in cancer","volume":"5","author":"McCubrey","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.jmgm.2019.06.008_bib23","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1074\/jbc.M112.409250","article-title":"Inhibition of glycogen synthase kinase-3 ameliorates \u03b2-amyloid pathology and restores lysosomal acidification and mammalian target of rapamycin activity in the alzheimer disease mouse model","volume":"288","author":"Avrahami","year":"2013","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jmgm.2019.06.008_bib24","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.arr.2012.06.003","article-title":"Tau protein kinases: involvement in Alzheimer's disease","volume":"12","author":"Martin","year":"2013","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.jmgm.2019.06.008_bib25","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/emboj\/20.1.27","article-title":"Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice","volume":"20","author":"Lucas","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/j.jmgm.2019.06.008_bib26","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/4209475","article-title":"GSK-3\u03b2 at the intersection of neuronal plasticity and neurodegeneration","author":"Jaworski","year":"2019","journal-title":"Neural Plast."},{"key":"10.1016\/j.jmgm.2019.06.008_bib27","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/sj.mp.4001483","article-title":"GSK-3beta inhibition reverses axonal transport defects and behavioural phenotypes in Drosophila","volume":"9","author":"Mudher","year":"2004","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jmgm.2019.06.008_bib28","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1046\/j.1471-4159.1999.0720576.x","article-title":"Insulin transiently increases tau phosphorylation: involvement of glycogen synthase kinase-3beta and Fyn tyrosine kinase","volume":"72","author":"Lesort","year":"1999","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.jmgm.2019.06.008_bib29","first-page":"46","article-title":"GSK-3\u03b2, a pivotal kinase in Alzheimer disease","volume":"7","author":"Llorens-Mart\u00edn","year":"2014","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.jmgm.2019.06.008_bib30","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1172\/JCI64516","article-title":"Inhibition of GSK3\u03b2-mediated BACE1 expression reduces Alzheimer-associated phenotypes","volume":"123","author":"Ly","year":"2013","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.jmgm.2019.06.008_bib31","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.neuron.2007.01.029","article-title":"LTP inhibits LTD in the hippocampus via regulation of GSK3beta","volume":"53","author":"Peineau","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.jmgm.2019.06.008_bib32","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1111\/j.1471-4159.2007.05194.x","article-title":"The GSK3 hypothesis of Alzheimer's disease","volume":"104","author":"Hooper","year":"2008","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.jmgm.2019.06.008_bib33","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1517\/14728222.12.11.1443","article-title":"GSK3beta: a master switch and a promising target","volume":"12","author":"Kannoji","year":"2008","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.jmgm.2019.06.008_bib34","doi-asserted-by":"crossref","first-page":"280502","DOI":"10.4061\/2011\/280502","article-title":"Glycogen synthase kinase 3 inhibitors in the next horizon for Alzheimer's disease treatment","volume":"2011","author":"Martinez","year":"2011","journal-title":"Int. J. Alzheimer's Dis."},{"key":"10.1016\/j.jmgm.2019.06.008_bib35","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S0002-9440(10)63465-7","article-title":"Co-localization of glycogen synthase kinase-3 with neurofibrillary tangles and granulovacuolar degeneration in transgenic mice","volume":"163","author":"Ishizawa","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jmgm.2019.06.008_bib36","doi-asserted-by":"crossref","first-page":"571","DOI":"10.7150\/thno.14334","article-title":"Glycogen synthase kinase-3 (GSK-3)-Targeted therapy and imaging","volume":"6","author":"Pandey","year":"2016","journal-title":"Theranostics"},{"key":"10.1016\/j.jmgm.2019.06.008_bib37","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/nrn2870","article-title":"GSK3 signalling in neural development","volume":"11","author":"Hur","year":"2010","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.jmgm.2019.06.008_bib38","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1107\/S090744490302938X","article-title":"Structural insight into nucleotide recognition in tau-protein kinase I\/glycogen synthase kinase 3 beta","volume":"60","author":"Aoki","year":"2004","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.jmgm.2019.06.008_bib39","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera--a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.jmgm.2019.06.008_bib40","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1021\/ci049714+","article-title":"ZINC \u2013 a free database of commercially available compounds for virtual screening","volume":"45","author":"Irwin","year":"2005","journal-title":"J.\u00a0Chem. Inf. Model."},{"key":"10.1016\/j.jmgm.2019.06.008_bib41","doi-asserted-by":"crossref","DOI":"10.1590\/1414-431x20165644","article-title":"Non-clinical studies required for new drug development - Part I: early in silico and in\u00a0vitro studies, new target discovery and validation, proof of principles and robustness of animal studies","volume":"49","author":"Andrade","year":"2016","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.jmgm.2019.06.008_bib42","article-title":"Structural and energetic understanding of novel natural inhibitors of Mycobacterium tuberculosis malate synthase","author":"Shukla","year":"2018","journal-title":"J.\u00a0Cell. Biochem."},{"key":"10.1016\/j.jmgm.2019.06.008_bib43","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1021\/jm051197e","article-title":"MolDock: a new technique for high-accuracy molecular docking","volume":"49","author":"Thomsen","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.jmgm.2019.06.008_bib44","first-page":"1","article-title":"Identification of novel natural inhibitors of Opisthorchis felineus cytochrome P450 using structure-based screening and molecular dynamic simulation","author":"Shukla","year":"2017","journal-title":"J.\u00a0Biomol. Struct. Dyn."},{"key":"10.1016\/j.jmgm.2019.06.008_bib45","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1080\/07391102.2017.1344141","article-title":"Identification of potential inhibitors of Fasciola gigantica thioredoxin1: computational screening, molecular dynamics simulation, and binding free energy studies","volume":"36","author":"Shukla","year":"2018","journal-title":"J.\u00a0Biomol. Struct. Dyn."},{"key":"10.1016\/j.jmgm.2019.06.008_bib46","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1080\/07391102.2017.1341337","article-title":"Structure-based screening and molecular dynamics simulations offer novel natural compounds as potential inhibitors of Mycobacterium tuberculosis isocitrate lyase","volume":"36","author":"Shukla","year":"2018","journal-title":"J.\u00a0Biomol. Struct. Dyn."},{"key":"10.1016\/j.jmgm.2019.06.008_bib47","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1021\/ci300367a","article-title":"admetSAR: a comprehensive source and free tool for assessment of chemical ADMET properties","volume":"52","author":"Cheng","year":"2012","journal-title":"J.\u00a0Chem. Inf. Model."},{"key":"10.1016\/j.jmgm.2019.06.008_bib48","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1002\/jcb.26444","article-title":"Structural insights into natural compounds as inhibitors of Fasciola gigantica thioredoxin glutathione reductase","volume":"119","author":"Shukla","year":"2018","journal-title":"J.\u00a0Cell. Biochem."},{"key":"10.1016\/j.jmgm.2019.06.008_bib49","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2009","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.jmgm.2019.06.008_bib50","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.jmgm.2019.06.008_bib51","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.bbrc.2017.06.036","article-title":"Alterations in conformational topology and interaction dynamics caused by L418A mutation leads to activity loss of Mycobacterium tuberculosis isocitrate lyase","volume":"490","author":"Shukla","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jmgm.2019.06.008_bib52","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1\u20132","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"key":"10.1016\/j.jmgm.2019.06.008_bib53","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1107\/S0907444904011679","article-title":"PRODRG: a tool for high-throughput crystallography of protein-ligand complexes","volume":"60","author":"Schuittelkopf","year":"2004","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.jmgm.2019.06.008_bib54","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1002\/jcc.20090","article-title":"A\u00a0biomolecular force field based on the free enthalpy of hydration and solvation: the GROMOS force-field parameter sets 53A5 and 53A6","volume":"25","author":"Oostenbrink","year":"2004","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.jmgm.2019.06.008_bib55","first-page":"1","article-title":"Virtual Screening, Pharmacokinetics, Molecular dynamics and binding free energy analysis for small natural molecules against Cyclin-dependent kinase 5 for Alzheimer's disease","author":"Shukla","year":"2019","journal-title":"J.\u00a0Biomol. Struct. Dyn."},{"key":"10.1016\/j.jmgm.2019.06.008_bib56","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.tube.2018.06.013","article-title":"Alternate pathway to ascorbate induced inhibition of Mycobacterium tuberculosis","volume":"111","author":"Shukla","year":"2018","journal-title":"Tuberculosis"},{"issue":"33\u201338","key":"10.1016\/j.jmgm.2019.06.008_bib57","first-page":"27","article-title":"VMD: visual molecular dynamics","volume":"14","author":"Humphrey","year":"1996","journal-title":"J.\u00a0Mol. Graph."},{"key":"10.1016\/j.jmgm.2019.06.008_bib58","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1021\/ci500020m","article-title":"g_mmpbsa--a GROMACS tool for high-throughput MM-PBSA calculations","volume":"54","author":"Kumari","year":"2014","journal-title":"J.\u00a0Chem. Inf. Model."},{"key":"10.1016\/j.jmgm.2019.06.008_bib59","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/s41598-017-01235-z","article-title":"Distant Phe345 mutation compromises the stability and activity of Mycobacterium tuberculosis isocitrate lyase by modulating its structural flexibility","volume":"7","author":"Shukla","year":"2017","journal-title":"Sci. Rep."}],"container-title":["Journal of Molecular Graphics and Modelling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326319302645?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326319302645?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T21:00:37Z","timestamp":1761080437000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1093326319302645"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":58,"alternative-id":["S1093326319302645"],"URL":"https:\/\/doi.org\/10.1016\/j.jmgm.2019.06.008","relation":{},"ISSN":["1093-3263"],"issn-type":[{"value":"1093-3263","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of novel small molecules against GSK3\u03b2 for Alzheimer's disease using chemoinformatics approach","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular Graphics and Modelling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmgm.2019.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}